TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study
{{output}}
Background: Combination regimens and monotherapy are both employed in the treatment of hepatocellular carcinoma (HCC). However, the optimal combination regimen for specific scenarios remains unclear. Therefore, our aim is to iden... ...